Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed A Gaballa

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Cardiac Failure|January 30, 2003
Ventricular remodeling in heart failureMohamed A Gaballa, Steven Goldman
Current Vascular Pharmacology|February 3, 2007
Do adult stem cells ameliorate the damaged myocardium? Human cord blood as a potential source of stem cellsElise M K Furfaro, Mohamed A Gaballa
Clinical Medicine (London, England)|September 5, 2009
Human umbilical cord blood stem cells, myocardial infarction and strokeNathan Copeland, David Harris, Mohamed A Gaballa
Cardiovascular Drug Reviews|December 4, 2003
Stem cell therapy in ischemic heart diseaseJulia N E Sunkomat, Mohamed A Gaballa
Plos One|June 5, 2012
Cardiac explant-derived cells are regulated by Notch-modulated mesenchymal transitionLiudmila Zakharova, Hikmet Nural-Guvener, Mohamed A Gaballa
Neuroscience Letters|November 7, 2012
BACE1 levels are elevated in congestive heart failureHikmet F Nural-Guvener, Nezahet Mutlu, Mohamed A Gaballa
American Journal of Physiology. Heart and Circulatory Physiology|July 19, 2002
Simvastatin restores endothelial NO-mediated vasorelaxation in large arteries after myocardial infarctionKathryn Bates, Charles E Ruggeroli, Steven Goldman, et al.
Expert Opinion on Biological Therapy|August 31, 2007
The potential of cord blood stem cells for use in regenerative medicineDavid T Harris, Michael Badowski, Nafees Ahmad, et al.
Journal of Cardiovascular Pharmacology|September 30, 2004
Thyroid hormone analog, DITPA, improves endothelial nitric oxide and beta-adrenergic mediated vasorelaxation after myocardial infarctionPeter H Spooner, Hoang M Thai, Steven Goldman, et al.
Journal of Cardiovascular Pharmacology|December 20, 2007
Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxationHoang Thai, David Guarraia, Nicholle Johnson, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cardiac Failure|January 30, 2003
Ventricular remodeling in heart failureMohamed A Gaballa, Steven Goldman
Current Vascular Pharmacology|February 3, 2007
Do adult stem cells ameliorate the damaged myocardium? Human cord blood as a potential source of stem cellsElise M K Furfaro, Mohamed A Gaballa
Clinical Medicine (London, England)|September 5, 2009
Human umbilical cord blood stem cells, myocardial infarction and strokeNathan Copeland, David Harris, Mohamed A Gaballa
Cardiovascular Drug Reviews|December 4, 2003
Stem cell therapy in ischemic heart diseaseJulia N E Sunkomat, Mohamed A Gaballa
Plos One|June 5, 2012
Cardiac explant-derived cells are regulated by Notch-modulated mesenchymal transitionLiudmila Zakharova, Hikmet Nural-Guvener, Mohamed A Gaballa
Neuroscience Letters|November 7, 2012
BACE1 levels are elevated in congestive heart failureHikmet F Nural-Guvener, Nezahet Mutlu, Mohamed A Gaballa
American Journal of Physiology. Heart and Circulatory Physiology|July 19, 2002
Simvastatin restores endothelial NO-mediated vasorelaxation in large arteries after myocardial infarctionKathryn Bates, Charles E Ruggeroli, Steven Goldman, et al.
Expert Opinion on Biological Therapy|August 31, 2007
The potential of cord blood stem cells for use in regenerative medicineDavid T Harris, Michael Badowski, Nafees Ahmad, et al.
Journal of Cardiovascular Pharmacology|September 30, 2004
Thyroid hormone analog, DITPA, improves endothelial nitric oxide and beta-adrenergic mediated vasorelaxation after myocardial infarctionPeter H Spooner, Hoang M Thai, Steven Goldman, et al.
Journal of Cardiovascular Pharmacology|December 20, 2007
Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxationHoang Thai, David Guarraia, Nicholle Johnson, et al.
Pageof 3